Kenvue Declares Quarterly Cash Dividend

SUMMIT, N.J.--(BUSINESS WIRE)-- Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on November 26, 2025, to shareholders of record as of the close of business on November 12, 2025.

About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251029321114/en/

Investor Relations:
Sofya Tsinis
[email protected]

Media Relations:
Melissa Witt
[email protected]

Source: Kenvue

You May Also Be Interested In

• SYNCERE introduces LUME during New York Fashion Week
• Ascent Solar Technologies (NASDAQ: ASTI) Strengthens Defense & Space Strategy as NASA Results, Multi-Orbit Testing and Drone Demand Accelerate
• $9.9 Million Revenue for First Half of 2026, a 25% Increase Over Same Period in 2025 for Emerging AI and Robotics Developer Baird Medical Investment Holdings (Nasdaq: BDMD)